Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma
Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma have?
Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma has 184 citations in the OpenAlex counts ScholarIQ stores.
When was Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma published?
Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma has 2015 year in the ScholarIQ index.
What is the open-access status of Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma?
Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma has green oa status in the ScholarIQ index.
What is the DOI of Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma?
The DOI for Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma is on the source record.
What is the PMID of Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma?
The PMID for Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma is on the source record.
What is the OpenAlex record for Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma?
The OpenAlex for Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma is on the source record.